Florian Gunzer

Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.

Gnotobiotic piglets as an animal model for oral infection with O157 and non-O157 serotypes of STEC.

Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells.

Comparison of a shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of shiga toxin-producing Escherichia coli in human stool specimens.

An extended transcriptional regulatory network of Escherichia coli and analysis of its hierarchical structure and network motifs.

Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules.

Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data.

Candida kefyr as an emerging pathogen causing nosocomial bloodstream infections in neutropenic leukemia patients.

The host response to the probiotic Escherichia coli strain Nissle 1917: specific up-regulation of the proinflammatory chemokine MCP-1.

Impact of the rpoS genotype for acid resistance patterns of pathogenic and probiotic Escherichia coli.

Sensitivity to Escherichia coli Nissle 1917 in mice is dependent on environment and genetic background.

Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

Selective activation of human intestinal mast cells by Escherichia coli hemolysin.

IRSp53 links the enterohemorrhagic E. coli effectors Tir and EspFU for actin pedestal formation.

High-throughput microarray technology in diagnostics of enterobacteria based on genome-wide probe selection and regression analysis.

Periplasmic delivery of biologically active human interleukin-10 in Escherichia coli via a sec-dependent signal peptide.

Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.

Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging.

Improving health from the inside: Use of engineered intestinal microorganisms as in situ cytokine delivery system.

Actinobacillus equuli ssp. haemolyticus in a semi-occlusively treated horse bite wound in a 2-year-old girl.

Secretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia coli via a modified Sec-dependent transporter construct.

Comparison of VITEK2, MALDI-TOF MS, and 16S rDNA sequencing for identification of Myroides odoratus and Myroides odoratimimus.

Development of a rapid microarray-based DNA subtyping assay for the alleles of Shiga toxins 1 and 2 of Escherichia coli.

Pathogenic vibrios in environmental, seafood and clinical sources in Germany.

First report on the isolation of Aureimonas altamirensis from a patient with peritonitis.

Complete Sequence of Probiotic Symbioflor 2 Escherichia coli Strain G3/10 and Draft Sequences of Symbioflor 2 E. coli Strains G1/2, G4/9, G5, G6/7, and G8.

Virulence genes in a probiotic E. coli product with a recorded long history of safe use.

The prediction of virulence based on presence of virulence genes in E. coli may not always be accurate.

Therapy of solid tumors using probiotic Symbioflor-2 - restraints and potential.